Literature DB >> 24362724

Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?

Jeffrey Saland1.   

Abstract

Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24362724     DOI： 10.1007/s00467-013-2722-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  20 in total

1.  Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report.

Authors:  Alon B Neidich; Eitan M Neidich; Andy Lee; Julie Nicoletta; Richard J Rohrer; Lawrence S Milner; Jeffrey T Cooper
Journal:  Prog Transplant       Date:  2013-09       Impact factor: 1.187

2.  Management of hemolytic uremic syndrome.

Authors:  Chantal Loirat; Jeffrey Saland; Martin Bitzan
Journal:  Presse Med       Date:  2012-01-27       Impact factor: 1.228

Review 3.  Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

4.  Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Michele Colledan; Bruno Gridelli; Alessandro Bertani; Paola Bettinaglio; Sara Bucchioni; Aurelio Sonzogni; Ezio Bonanomi; Valter Sonzogni; Jeffrey L Platt; Norberto Perico; Marina Noris
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

Review 5.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

6.  Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.

Authors:  J M Saland; S H Emre; B L Shneider; C Benchimol; S Ames; J S Bromberg; G Remuzzi; L Strain; T H J Goodship
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

7.  Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Authors:  C M Legendre; C Licht; P Muus; L A Greenbaum; S Babu; C Bedrosian; C Bingham; D J Cohen; Y Delmas; K Douglas; F Eitner; T Feldkamp; D Fouque; R R Furman; O Gaber; M Herthelius; M Hourmant; D Karpman; Y Lebranchu; C Mariat; J Menne; B Moulin; J Nürnberger; M Ogawa; G Remuzzi; T Richard; R Sberro-Soussan; B Severino; N S Sheerin; A Trivelli; L B Zimmerhackl; T Goodship; C Loirat
Journal:  N Engl J Med       Date:  2013-06-06       Impact factor: 91.245

8.  Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.

Authors:  Thomas A Forbes; Mark G Bradbury; Tim H J Goodship; Patrick J McKiernan; David V Milford
Journal:  Pediatr Transplant       Date:  2013-03-06

9.  Attempted treatment of factor H deficiency by liver transplantation.

Authors:  Hae Il Cheong; Byong Sop Lee; Hee-Gyung Kang; Hyewon Hahn; Kyung-Suk Suh; Il Soo Ha; Yong Choi
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

10.  Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.

Authors:  Colin Wilson; Nick Torpey; Bryon Jaques; Lisa Strain; David Talbot; Derek Manas; Tim Goodship
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860
View more
  19 in total

Review 1.  Liver involvement in kidney disease and vice versa.

Authors:  Karen Van Hoeve; Djalila Mekahli; Eva Morava; Elena Levtchenko; Peter Witters
Journal:  Pediatr Nephrol       Date:  2017-06-23       Impact factor: 3.714

Review 2.  Thrombotic microangiopathies: a general approach to diagnosis and management.

Authors:  Donald M Arnold; Christopher J Patriquin; Ishac Nazy
Journal:  CMAJ       Date:  2016-10-17       Impact factor: 8.262

Review 3.  Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-07-06

4.  Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.

Authors:  Emmanuel Gonzales; Tim Ulinski; Dalila Habes; Georges Deschênes; Véronique Frémeaux-Bacchi; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2016-10-15       Impact factor: 3.714

Review 5.  Current treatment of atypical hemolytic uremic syndrome.

Authors:  Bernard S Kaplan; Rebecca L Ruebner; Joann M Spinale; Lawrence Copelovitch
Journal:  Intractable Rare Dis Res       Date:  2014-05

Review 6.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

7.  Success of eculizumab in the treatment of atypical hemolytic uremic syndrome.

Authors:  Esra Baskin; Kaan Gulleroglu; Asli Kantar; Umut Bayrakci; Ozan Ozkaya
Journal:  Pediatr Nephrol       Date:  2014-11-11       Impact factor: 3.714

Review 8.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

Review 9.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Jens Van Praet; Karl A Nath; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 10.121

10.  Liver transplantation for aHUS: still needed in the eculizumab era?

Authors:  Rosanna Coppo; Roberto Bonaudo; R Licia Peruzzi; Alessandro Amore; Andrea Brunati; Renato Romagnoli; Mauro Salizzoni; Miriam Galbusera; Eliana Gotti; Erica Daina; Marina Noris; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2015-11-24       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.